Management Plan for 33-Year-Old Woman with Epigastric Pain, Nausea, and Vomiting
This patient should receive empirical treatment with a proton pump inhibitor (PPI) for 4-8 weeks after testing for H. pylori, without initial imaging or endoscopy, given her age under 55 years, stable vital signs, and absence of alarm features. 1
Initial Assessment and Risk Stratification
The key decision point here is the absence of alarm features. This patient has:
- Age < 55 years
- Normal vital signs (ruling out hemodynamic instability)
- No peritoneal signs (no rebound tenderness, no focal tenderness)
- No evidence of perforation or acute surgical abdomen
The differential diagnosis includes GERD, peptic ulcer disease, gastritis, duodenal ulcer, and functional dyspepsia—all of which present with overlapping symptoms of epigastric pain, nausea, and vomiting 2.
Recommended Management Algorithm
Step 1: H. pylori Testing
Test for H. pylori using either:
- 13C-urea breath test (preferred), OR
- Stool antigen test
Do NOT use serology as it cannot distinguish active from past infection 1.
Step 2: Treatment Based on H. pylori Status
If H. pylori POSITIVE:
- Treat with appropriate eradication therapy
- This prevents future gastric adenocarcinoma and resolves symptoms in most cases
- Retest after treatment to confirm eradication
If H. pylori NEGATIVE:
- Start empirical PPI therapy for 4-8 weeks
- PPIs are the drug class of choice over H2-receptor antagonists 1
Step 3: Symptomatic Management
While awaiting test results or during treatment:
- IV fluid replacement if dehydration is present from vomiting
- 5-HT3 receptor antagonists (ondansetron) are preferred antiemetics as they act on both central and peripheral receptors 3
- Correct electrolyte abnormalities if present
When Imaging is NOT Indicated
No initial imaging is needed for this patient because 2:
- CT abdomen/pelvis is not the test of choice when acid reflux, gastritis, or peptic ulcer is suspected
- Imaging is reserved for when symptoms suggest complications (perforation, obstruction) or when empirical therapy fails
- Upper GI series or barium studies are only indicated when symptoms are nonspecific and multiple differential diagnoses need evaluation
When to Consider Endoscopy
Endoscopy is NOT indicated initially but should be considered if 1:
- Symptoms persist after H. pylori eradication AND 4-8 weeks of PPI therapy
- Alarm features develop (hematemesis, weight loss, dysphagia, anemia)
- Patient is ≥55 years old at presentation
- There is concern for gastric cancer based on risk factors
Critical Pitfalls to Avoid
Don't order CT imaging reflexively: This patient's presentation doesn't warrant imaging unless you suspect perforation (which would show peritoneal signs) or obstruction (which would show distension and abnormal bowel sounds)
Don't skip H. pylori testing: Even in low-prevalence populations, testing is cost-effective and prevents future complications including gastric cancer 1
Don't use empirical PPI alone without testing: The test-and-treat strategy is superior because it addresses the underlying cause and has long-term cancer prevention benefits
Don't assume GERD without trial: While GERD is common (42% of Americans have monthly heartburn), this patient's predominant symptoms are epigastric pain with vomiting, not heartburn/regurgitation 1
Expected Outcome
Most patients (>50%) with this presentation have functional dyspepsia and will respond to empirical therapy. Only about 10% have peptic ulcer disease 1. Endoscopy adds little value in young patients without alarm features and should be reserved for treatment failures or when reassurance is specifically needed after failed empirical therapy.